Meet The Donors

RhoGAM > Patient > Plasma Donor Program > Meet The Donors

Meet The Donors

The RhoGAM^® Brand donor program is a close-knit group of familiar names and faces. Their gift of plasma represents the commitment of one special family to all families. Meet some of the wonderful people behind the product.

THE PEOPLE BEHIND THE PRODUCT

Marilyn M.—Hemolytic Disease of the Newborn (HDN) took three of her babies, but she’s helped saved thousands as a RhoGAM^® Brand donor.

Elizabeth P. - Turning a Negative into a Positive

Elizabeth Pascoe

©Ortho-Clinical Diagnostics, Inc. 2006-2009
This site is published by Ortho-Clinical Diagnostics Inc. USA, which is solely responsible for its content.
US Flag

This site contains U.S. based product information only.

Important Safety Information

RhoGAM^® and MICRhoGAM^® Ultra-Filtered PLUS Rh_o(D) Immune Globulin (Human) are made from human plasma. Since all plasma-derived products are made from human blood, they may carry a risk of transmitting infectious agents, e.g., viruses, and theoretically the Creutzfeldt-Jakob disease (CJD) agent. RhoGAM^® and MICRhoGAM^® are intended for maternal administration. Do not inject the newborn infant. Local adverse reactions may include redness, swelling, and mild pain at the site of injection and a small number of patients have noted a slight elevation in temperature. Patients should be observed for at least 20 minutes after administration. Hypersensitivity reactions include hives, generalized urticaria, tightness of the chest, wheezing, hypotension and anaphylaxis. RhoGAM^® and MICRhoGAM^® contain a small quantity of IgA and physicians must weigh the benefit against the potential risks of hypersensitivity reactions. Patients who receive RhoGAM^® and MICRhoGAM^® for Rh-incompatible transfusion should be monitored by clinical and laboratory means due to the risk of a hemolytic reaction.

For full prescribing information regarding the safe and effective use of RhoGAM® Brand, click here

Last Published Date : 5/26/2009 7:42 PM